Blog

MBI Researchers identify new immunotherapy targets for medulloblastoma

Photo taken from McKnight Brain Institute of the University of Florida/LinkedIn

Aug 21, 2024, 14:07

MBI Researchers identify new immunotherapy targets for medulloblastoma

McKnight Brain Institute of the University of Florida shared on LinkedIn:

“MBI researchers led a study published today in Genome Medicine analyzing genetic data from 170 medulloblastoma patients across four subtypes to identify potential new targets for immunotherapy treatment of the disease.

‘This work provides a foundation for developing more personalized immunotherapies that could be safer and more effective than current treatments,’ said first author Dr. Changlin Yang.”

‘Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma‘

Authors: Changlin Yang, Vrunda Trivedi, Kyle Dyson, Tongjun Gu, Kate M. Candelario, Oleg Yegorov and Duane A. Mitchell

MBI Researchers identify new immunotherapy targets for medulloblastoma

Source: McKnight Brain Institute of the University of Florida/LinkedIn

cancer Changlin Yang Duane A. Mitchell Genome Medicine immunotherapy Kate M. Candelario Kyle Dyson McKnight Brain Institute of the University of Florida medulloblastoma Oleg Yegorov OncoDaily Oncology Tongjun Gu Vrunda Trivedi

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity